[unable to retrieve full-text content] Lenacapavir HIV shot approved in US may enter Canada by 2026; just two injections needed a year The Economic Times
[unable to retrieve full-text content] Flu and People Living with HIV | Influenza (Flu) Centers for Disease Control and Prevention | CDC (.gov)
[unable to retrieve full-text content] When will the HIV prevention pill go generic? Teva won't say, pointing to a confidential settlement STAT
[unable to retrieve full-text content] Virological treatment failure and associated factors among adults on first-line antiretroviral therapy in West Hararghe, Ethiopia Frontiers
[unable to retrieve full-text content] Virological treatment failure and associated factors among adults on first-line antiretroviral therapy in West Hararghe, Ethiopia Frontiers
[unable to retrieve full-text content] Chlamydia and Perihepatitis (Fitz-Hugh-Curtis Syndrome) in an 18-Year-Old Male: A Case Report Cureus
[unable to retrieve full-text content] Challenges and Opportunities for Consideration of Efavirenz Drug Repurposing for Alzheimer's Disease Therapeutics ACS Publications
[unable to retrieve full-text content] Merck Announces Topline Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) for the Treatment of Adults with Virologically Suppressed HIV-1 Infection Business Wire